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Abstract 
Sera from 17 166 blood donors living in 10 cantons of northern Switzerland in an area endemic for 
Echinococcus multilocularis were investigated by serological survey for alveolar echinococcosis (AE). A 
highly species-specific antigen (Em2) and a commonly used E. granulosus hydatid fluid antigen 
(EgHF) were compared for their suitability in seroepidemiology. EgHF showed a degree of 
nonspecificity which did not allow direct detection of AE cases. Antibody reaction with Em2 resulted 
in the detection of 2 asymptomatic clinical cases of AE (seroprevalence 0.01%) within this population 
of blood donors. A further 4 persons were positive in Em2-ELISA. These 4 persons had negative 
imaging studies and will be followed serologically and clinically. 
Introduction 
Alveolar echinococcosis (AE) is a zoonotic disease 
caused by the larval stage (metacestode) ofEchinococ- 
cus multilocularis. There is evidence that the infection 
is acquired many years before clinical manifestation of 
the disease. At the time when symptoms occur, 
pathological lesions in the liver, and sometimes other 
organs, have progressed so far that 42 to 74% of the 
patients are inoperable (SCHANTZ et al., 1982; 
SCHANTZ & GOTTSTEIN, 1986). In these cases, and 
also after partial resection of liver lesions, the 
prognosis is unfavourable. In patients not submitted 
to specific chemotherapy lethality is very high, 
reaching 94% within 10 years after diagnosis of the 
disease (SCHICKER, 1976). 
In Switzerland echinococcosis is well known as a 
public health hazard. Between 1956 and 1969 an 
annual average of 8.7 new cases of AE was diagnosed, 
amounting to 122 cases (DROLSHAMMER et al., 1973). 
The annual morbidity rate per 100 000 inhabitants 
was 0.14. Most cases were of Swiss nationality and in 
the aee arouo between 51 and 60 years. The highest 
number-of cases was found in the northern pacts of 
the countrv. Recentlv. for the neriod 1970 to 1983, an 
annual average of 16kew case’s of AE, with a total of 
145 cases, has been registered (Gloor, unpublished 
observations). 
In Switzerland the epidemiological situation is 
comnlicated bv the fact that E. multiloculuris and E. 
grunulosus occur sympatrically (ECKERT, 1970; DROL- 
SHAMMER et al., 1973). 
The aim of the resent survey was to determine 
the prevalence an B geographical distribution of AE 
in a population of blood donors and to attempt 
early diagnosis of the infection. Early diagnosis and 
treatment may reduce mortality of the disease. The 
epidemiological situation of low prevalence re- 
quired a serological test system of high diagnostic 
sensitivity and species-specificity for the detection 
of infections with E. multilocularis. 
The purification of a species-specific antigenic 
polypeptide (Em2) from E. multilocularis 
metacestodes b affinity chromatography and its 
subsequent eva uation by enzyme-linked immuno- P 
sorbent assay (ELISA) demonstrated a high di- 
agnostic sensitivity (93.6%) and specificity with 
regard to cross-reactions due to nematode and 
trematode infections (100%) and to cestode infec- 
tions (95%) (GOTTSTEIN et al., 1983; 1986a; Gore- 
STEIN, 1985). 
This paper summarizes the results of 2 
seroepidemiological studies on AE in northern 
Switzerland carried out by 2 institutions, particularly 
regarding the relative potential of EM2 and EgHF as 
immunodiagnostic tools for sero-epidemiology ofAE. 
Materials and Methods 
Sera from 12 000 healthy blood donors were obtained 
between September 1984 and March 1985 from 9 cantons of 
northern Switzerland (Aargau, 1495; Appenzell, 109; Basel, 
2370; Bern, 279; Schaffhausen, 1158; Solothurn, 197; St 
Gallen, 369; Thurgau, 4932; Zurich, 1091) which are 
endemic areas of AE (DROLSHAMMER et al., 1973) (Fig. 1). 
The sera were collected by mobile teams of the Central 
Laboratory of the Blood Transfusion Service (Swiss Red 
Cross) and by local blood donation centres at Frauenfeld and 
Munsterlingen. These sera were selected for direct testing 
with Em2 by ELISA. Further sera were obtained from 5166 
healthy blood donors originating from 2 other cantons (Jura 
including Jura bernois, Neuchatel) of the endemic area (Fig. 
1). These sera were collected by the regional blood 
transfusion centre of La Chaux-de-Fonds and were pretested 
with EgHF for comparative purposes. All sera were stored at 
-80°C till required. The following information was obtained 
concerning 9000 blood donors: 65% males and 35% females 
aged between 20 and 75 years (mean age for both sexes, 40 
years); 90% of all blood donors included in this study lived in 
rural or semirural areas. 
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The ELISA using Em2 was performed as described by 
GOTTSTEIN (1985), using the criteria for interpretation of 
seropositivity reported earlier (GOTTSTEIN et al., 1984). 
Briefly, the results are expressed as percentages of the 
maximum absorbence at 404nm of a positive reference serum 
minus mean value (2) plus 3 standard deviations (SD) of sera 
from healthy blood donors living in an area not endemic for 
E. multiloculuris (canton of Ticino). The ELISA using EgHF 
(fertile hydatid fluid of bovine origin) was carried out 
according to VOLLER et al. (1981) and positive sera were 
tested in a second step with Em2 for specificity confirmation. 
In both tests a result was considered “positive” (specific 
antibodies detectable) if its corresponding absorbance value 
was higher than % + 3 SD determined as described above. 
In order to exclude any error during sampling and proces- 
sing of the sera, a second blood sample was collected from all 
blood donors demonstrating antibody activity to Em2. 
The overall sensitivity (93.6%) and specificity (100%) of 
the ELISA for Em2 has been reported earlier (GOTTSTEIN, 
1985). For EgHF-ELISA, the sensitivity was 91% (GOTT- 
STEIN et al., 1986b), and the specificity with regard to an 
adult healthy Swiss population was 93.6% (ST~~RCHLER et 
al., 1986). The predictive values of positive and negative 
results were calculated for a hypothetical population of 
10 000 with 0.01% infected persons, which corresponds 
approximately to the clinical prevalence in the canton of 
Thurgau (JAEGER et al., 1979), as follows. 
Alveolar echinococcosis 
present absent 
Test result + a 
Test result - f; 
where a = expected number of &es x sensitivity/lOO, b = 
expected number of healthy blood donors x (100 - 
specificity)/lOO, c = expected number of AE cases x (100 - 
sensitivity)/lOO, and d = expected number of healthy blood 
donors X specificityi100. Then,, positive predictive 
value = al(a + b); negative predictive value = d/(c + d). 
Patients with a positive result in EmZ-ELISA were further 
investigated by ultrasound (US) and/or computer assisted 
tomography (CT) of the intra-abdominal and retroperitoneal 
organs. Both methods are very sensitive in diagnosing liver 
echinococcosis (HAERTEL et al., 1980; Orro et al., 1982). 
US, however, is slightly inferior to CT when imaging lesions 
of small size in the liver (OTTO et al., 1982). 
Predictive values 
Results 
The predictive value of positive results in Em2- 
ELISA was calculated to be >99%, based on specific- 
ity, sensitivity and prevalence data listed above. For 
EgHF-ELISA, the positive predictive value was only 
0.14%. The predictive value of a negative result was 
>99% for both Em2-ELISA and EgHF-ELISA. 
Sewepidemiology 
The results of the present survey with sera directly 
tested in Em2-ELISA are shown in Table 1. Sera 
from 5 blood donors had antibodies reacting with 
Em2. All these persons were submitted to imaging 
studies with either US or CT, or both. 
In 1 patient lesions were detected by imaging 
studies (see case histories). 4 persons had negative 
imaging studies and will be followed closely with 
periodic serology and US/CT studies. None of these 4 
persons’ serum showed arc-5 precipitation in im- 
munoelectrophoresis. Antibody concentrations in 
Em2-ELISA were 14%, 16%, 35% and 21%, respec- 
tively. In contrast, antibodies were not detected by 
ELISA using EgHF. 
The results of sera pretested by EgHF-ELISA with 
subsequent re-examination of the positive reactions 
by Em2-ELISA are shown in Table 2. Serum 
Table l-Prevalence of antibodies to species-specific polypeptide (Em2) antigen by ELISA in Swiss adult blood donors 
(sampled between September 1984 and March 1985) 
FoYP 
:I 
III 
Serological result’ 
Positive 
Positive 
Negative 
Clinical finding 
AE confirmed clinically 
No liver lesion detected by US/CT 
No investigation made 
Blood donors 
No. % 
1 0.01 
0.03 
1199: 99.96 
Total 
‘Positive: antibodies detected with EmZ-antigen. 
12 000 100~00 
Negative: no antibodies detected with EmZ-antigen. 
Abbreviations. AE: alveolar echinococcosis, US: ultrasound examination, CT: computer assisted tomography. 
Table 2-Prevalence of antibodies to E. grunulosus hydatid fluid (EgHF) antigen by ELISA in Swiss adult blood donors 
(sampled between October 1984 and May 1985) 
Group 
No. Serological result’ Clinical finding 
I Positive (EgHF-antigen), No liver lesion detected by US/CT 
negative (EmZ-antigen) 
II Positive (EgHF-antigen), 
positive (EmZ-antigen) 
AE confirmed clinically by US/CT 
III Negative (EgHF-antigen) No investigation made 
Total 
‘Positive: antibodies detected with EgHF or Em2 antigen. 
Negative: no antibodies detected with EgHF or Em2 antigen. 
Abbreviations: see Table 1. 
Blood donors 
No. % 
16 0.31 
1 0.02 
5149 99.67 
5166 100~00 
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Frauenfeld 
La 
Mtinsterlingen 
#Home of AE patient W.C. + Home of AE patient G.A. 0 Homes of 4 persons positive in Em2-ELISA; 
no liver lesion (US/CT), no sign of AE. @ Villages screened by mobile Bquipes for blood donation 
performances. @b Regional blood donation centres. 
Fig. 1. Map showing blood sampling areas and homes of EmZ-positive blood donors and patients with alveolar echinococcosis detected 
serologically. 
antibodies from 17 persons reacted in EgHF-ELISA, 
but only one serum was confirmed for specificity by 
Em2-ELISA. This EmZ-positive serum was from a 
22-year-old man (W.C.) with positive imaging studies 
(see case histories). All 16 persons “positive” by 
EgHF-ELISA but “negative” by Em2-ELBA 
showed no clinical sign of the presence of AE and will 
not be followed in this study. Fig. 1 shows the 
geographical location of all villages and areas screened 
in the present study, location of detected AE patients 
and healthy persons with antibodies to Em2 but 
negative imaging studies. Overall, the investigation of 
17 166 blood donors’ sera resulted in 2 patients 
positive by Em2-ELISA with clinically confirmed 
AE, a seroprevalence of clinically confirmed AE of 
0.01%. Furthermore, 4 persons were detected with 
antibody to Em2 but without clinical evidence of AE 
at the time of investigation, giving a total seropreva- 
lence of 0.03%. 
Case histories 
Patient G.A. (Table 1). A 41-year-old woman of 
Austrian origin, but living in Switzerland for 19 years. 
The ELISA revealed an antibody concentration of 
69% using Em2 and 77% using EgHF. Furthermore, 
arc-S was precipitated in immunoelectrophoresis. US 
and CT imaging demonstrated a lesion involving both 
lobes of the liver with a maximum diameter of about 
10 cm, compatible with AE (Fig. 2). A second lesion 
was found in the head of the pancreas. Due to the 
localization and extent of the lesions the patient was 
considered to be primarily inoperable and continuous 
;Erbeitherapy with mebendazole (2.5 g/d) was 
Patient W.C. (Table 2). A 22-year-old Swiss man. 
Antibody concentrations of 61% and 51% were 
obtained by Em2-ELISA and EgHF-ELISA respec- 
tively. No arc-5 was detectable by immunoelec- 
trophoresis. US showed a lesion in the right lobe of 
the liver with a maximum size of 6~ 7 cm (Fig. 3). In 
this patient a complete resection of the parasite lesion 
was performed by right side hemihepatectomy. 
Pathological examination confirmed AE. 
4 further persons, 3 men and a woman of Swiss 
nationality aged between 20 and 43 years, showed 
anti-Em2 antibody concentrations between 14% and 
35%. Detection of arc-5 in immunoelectrophoresis 
failed, one serum precipitating an arc which was not 
arc-S. US, CT, or both, did not demonstrate liver 
lesions. In order to ascertain whether the anti-Em2 
antibodies are related to early AE, these persons will 
be examined every 6 months by serology and every 
year by US. 
Discussion 
Experience with AE in Switzerland points to a 
fundamental need for a reliable method permitting an 
early diagnosis during the preclinical stage. If an 
organ lesion could be identified in an initial, small 
stage and before infiltrating bile ducts or major 
vessels, or before the formation of distant metastases, 
the surgical resectability rates and the prognosis of the 
disease should considerably improve. 
The use of Em2 for immunodiagnosis of AE has 
been assessed in a pilot study in Alaska (GOTTSTEIN et 
uE., 1985; SCHANTZ & GOTTSTEIN, 1986), which 
showed that lesions were detectable by Em2 which 
were not indicated by EgHF. This Alaskan study was 
designed for an area in which E. multilocularis is 
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Fig. 2. (a) Ultrasound (US) and (b) computer-assisted tomography 
(CT) findings in patient G.A. CT imaging clearly demonstrates the 
irregular lesion in both lobes of the liver with a maximum diameter of 
10 cm. In US the contour of the margin of the lesion appears mote 
sharply. In the section shown the diameters of the lesion (marked 
by + signs) were 6.6 cm and 7.9 cm, respectively. 
hyperendemic. Based on these results, and on the 
predictive values of Em2-ELISA, we designed the 
present study for an area of moderate endemicity. 
Despite the relatively low number of blood donors 
included in this study, the survey resulted in the 
detection of 2 asymptomatic, clinically confirmed 
cases of AE. One patient (G.A.), although asymp- 
tomatic, unfortunately had already reached an adv- 
anced stage of the disease and was considered to be 
inoperable. In the second patient (W.C.), however, 
the parasite lesion was small and completely resect- 
able. 
4 persons had positive Em2-serology but showed 
negative imaging studies (US and/or CT). Interesting- 
ly, 3 of these 4 persons lived in the canton of 
Thurgau, which has a slightly higher prevalence of 
human cases than the other cantons investigated 
(J~GER et al., 1979). Due to the high specificity of 
Fig. 3. Ultrasound imaging in patient W.C. showed a lesion caused 
by E. nulrilocularis in the right lobe of the liver. The extent of the 
lesion (+) was 4.8 cm. In this patient radical surgery was performed. 
Em2, false positive reactions due to heterologous 
infections can be excluded with a high degree of 
probability. Such positive antibody responses in 
asymptomatic persons without liver lesions may be 
due to early or abortive E. multilocularis infections, or 
possibly to challenge with eggs which did not develop 
into metacestodes. The lesions caused by the parasite 
could also be located in tissues not examined by 
routine imaging studies. This, however, is not very 
likely because primary lesions of AE are located in the 
liver in 98% to 100% of cases (DROLSHAMMER et al., 
1973). Studies in Alaska have already shown that 
Em2-ELISA detected asymptomatic ases not de- 
tected by other serological techniques (especially 
using antigens derived from E. granulosus), in which 
the larval cestode was of very small size and had died 
out at an apparently early stage of infection (BAUSCH 
et al., 1987). This was assessed through immunohis- 
tochemical tests and by inoculation of parasite mate- 
rial isolated from patients into susceptible rodents. 
The spontaneous death of larval E. multilocularis, 
which is known to occur in animals with high natural 
resistance against this parasite, like cattle and sheep 
(LUKASHENKO, 1971), was also postulated for hu- 
mans but has never yet been demonstrated. Such 
spontaneous rejection of the infection may also have 
occurred in the Swiss patients. These persons will be 
followed carefully by clinical and serological means; 
long-term studies on them will provide more informa- 
tion about the possibilities listed above which may be 
responsible for EmZ-seroconversion. 
The comparison of the use of Em2 and EgHF in 
ELISA for seroepidemiology clearly shows that, for 
assessing an endemic area with a relative low preva- 
lence of AE, there is an absolute need for a highly 
specific antigen like Em2. The use of a non-specific 
antigen like EgHF alone is of little value. 
The detection of 2 cases of AE among 17 166 blood 
donors implies a prevalence rate of 11.6 per 100 000. 
The total number of inhabitants of the age allowing 
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blood donation in the whole area of the present survey 
was estimated to be about 1 million. Therefore, about 
116 persons living in this area were expected to be 
infected with E. mulriloculuris at the time of the 
screening (1984/1985). JAGER et al. (1979) observed a 
morbiditv rate of 7.8 oer 100 000 in the canton of 
Thurgau- over a period of 10 years. Serological 
screening with Em2-ELISA will detect all persons 
infected with E. muZtiZocuZaris, e pecially early asymp- 
tomatic AE cases, which, if not detected by serology 
in a preclinical stage, may develop into symptomatic 
clinical cases of AE. Comparison of the results of the 
present survey with the clinical prevalence data of 
JAGER et al. (1979) is feasible only if we know the 
average number of years between infection and 
diagnosis of AE, based on clinical symptoms. Com- 
bining Jager’s data (annual morbidity rate per 100 000 
persons = 0.78, based on clinical findings) with ours 
(incidence rate per 100 000 persons = 11.6, based on 
serological findings), on average 15 years may be 
presumed to pass between time of infection and onset 
of symptoms (11.610.78 = 15). 
At present no reliable measures are available to 
control the disease in animal populations or to prevent 
infections of humans. Therefore, further sero- 
epidemiological surveys employing ELBA with Em2 
antigen should be carried -out in endemic areas to 
identifv locations of hieh transmission risk. If this 
could be achieved, local-sero-epidemiological surveys 
could be conducted in restricted groups of the 
population, to detect cases of asymptomatic AE at an 
early stage. However, the practical planning of such a 
screening system in areas of moderate endemicity 
requires more information, which should be obtained 
from various areas endemic for E. multilocularis. 
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